Biochemical and immunochemical characterisation of human diadenosine triphosphatase provides evidence for its identification with the tumour suppressor Fhit protein

Biochimie

Volumn 88, Issue 5, 2006, Pages 461-471

  Asensio, Aaron C ^a   Rodríguez Ferrer, Carmen R ^a   Oaknin, Sol ^a   Rotllán, Pedro ^a,b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b Madrid Spain   (Spain)

Author keywords

Cancer; Diadenosine triphosphatase; Diadenosine triphosphate; Fhit protein; Suramin

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIBODY; CALCIUM ION; DIADENOSINE TRIPHOSPHATASE; DIADENOSINE TRIPHOSPHATE; DIETHYL PYROCARBONATE; FRAGILE HISTIDINE TRIAD ANTIBODY; FRAGILE HISTIDINE TRIAD PROTEIN; HOMODIMER; MAGNESIUM ION; MANGANESE; MONOMER; PHOSPHATASE; POLYPEPTIDE; RECOMBINANT PROTEIN; SURAMIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ZINC ION; ACID ANHYDRIDE HYDROLASE; BIS(5' ADENOSYL)TRIPHOSPHATASE; BIS(5'-ADENOSYL)TRIPHOSPHATASE; DINUCLEOSIDE PHOSPHATE; TUMOR PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; GEL FILTRATION; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ION EXCHANGE; MICHAELIS CONSTANT; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; RAT; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; ANIMAL; BINDING SITE; BLOOD; BRAIN; DRUG EFFECT; ENZYME SPECIFICITY; ENZYMOLOGY; FLUOROMETRY; GEL CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; KINETICS; LEUKOCYTE; MALE; METABOLISM; METHODOLOGY; THROMBOCYTE; WISTAR RAT;

ACID ANHYDRIDE HYDROLASES; ANIMALS; BINDING SITES; BLOOD PLATELETS; BRAIN; CATALYSIS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINUCLEOSIDE PHOSPHATES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUOROMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; LEUKOCYTES; MALE; NEOPLASM PROTEINS; RATS; RATS, WISTAR; SUBSTRATE SPECIFICITY; SURAMIN; TUMOR SUPPRESSOR PROTEINS;

EID: 33745002486     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2005.10.006     Document Type: Article

References (52)

1. nA) a class of signalling molecules?. FEBS Lett. 427 (1998) 157-163
2. Guranowski A. Specific and nonspecific enzymes involved in the catabolism of mononucleoside and dinucleoside polyphosphates. Pharmacol. Ther. 87 (2000) 117-139
3. McLennan A.G. Dinucleoside polyphosphates-friend or foe?. Pharmacol. Ther. 87 (2000) 73-89
4. Pintor J., Díaz-Hernández M., Gómez-Villafuertes R., Gualix J., Hernando F., and Miras-Portugal M.T. Diadenosine polyphosphate receptors: from rat and guinea pig to human central nervous system. Pharmacol. Ther. 87 (2000) 103-115
5. P. Rotllán, A.C. Asensio, A. Ramos, C.R. Rodríguez-Ferrer, S. Oaknin, Ectoenzymatic hydrolysis of the signalling nucleotides diadenosine polyphosphates, in: Recent Research Developments in Biochemistry, vol. 3, Research Signpost, Trivandrum, 2002, pp. 191-209.
6. 4-tetraphosphate in cell cycle arrest and regulation of apoptosis. Biochem. Pharmacol. 65 (2003) 227-235
7. 5-Di(adenosine-5′)pentaphosphate, a potent multisubstrate inhibitor of adenylate kinase. J. Biol. Chem. 248 (1973) 1121-1123
8. Rotllán P., and Miras-Portugal M.T. Adenosine kinase from bovine adrenal medulla. Eur. J. Biochem. 151 (1985) 365-371
9. Ramos A., and Rotllán P. Specific dinucleoside polyphosphate cleaving enzymes from chromaffin cells: a fluorimetric study. Biochim. Biophys. Acta 1253 (1995) 103-111
10. Bessman M.J., Frick D.N., and O'Handley S.F. The MutT proteins or "Nudix" hydrolases, a family of versatile, widely distributed, "housecleaning" enzymes. J. Biol. Chem. 271 (1996) 25059-25062
11. 3-triphosphate hydrolase. Biochemistry 36 (1996) 11529-11535
12. Pace H.C., Garrison P.N., Robinson A.K., Barnes L.D., Draganescu A., Rösler A., Blackburn G.M., Siprasvili Z., Croce C.M., Huebner K., and Brenner C. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signalling form of Fhit. Proc. Natl. Acad. Sci. USA 95 (1998) 5484-5489
13. Brenner C. Hint, Fhit and GalT: Function, structure, evolution, and mechanism of the three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry 41 (2002) 9003-9014
14. Brenner C., Pace H.C., Garrison P.N., Robinson A.K., Roster A., Liu X., Blackburn G.M., Croce C.M., Huebner K., and Barnes L.D. Purification and crystallization of complexes modelling the active state of the fragile histidine triad protein. Protein Eng. 10 (1997) 1461-1463
15. Pawelczyk T., Kowara R., Golebiowski F., and Matecki A. Expression in Escherichia coli and simple purification of human Fhit protein. Protein Expr. Purif. 18 (2000) 320-326
16. Siprashvili Z., Sozzi G., Barnes L.D., McCue P., Robinson A.K., Eryomin V., Sard L., Tagliabue E., Greco A., Fusetti L., Schwartz G., Pierotti M.A., Croce C.M., and Huebner K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA 94 (1997) 13771-13776
17. Huebner K., Garrison P.N., Barnes L.D., and Croce C.M. The role of the FHIT/FRA3B locus in cancer. Ann. Rev. Genet. 32 (1998) 7-31
18. Pekarsky Y., Zanesi N., Palamarchuk A., Huebner K., and Croce C.M. FHIT: from discovery to cancer treatment and prevention. Lancet Oncol. 3 (2002) 748-754
19. Murphy G.A., Halliday D., and McLennan A.G. The Fhit suppressor tumor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate. Cancer Res. 60 (2000) 2342-2344
20. Lobatón C.D., Sillero M.A.G., and Sillero A. Diadenosine triphosphate splitting by rat liver extracts. Biochem. Biophys. Res. Commun. 67 (1975) 279-286
21. Sillero M.A.G., Villalba R., Moreno A., Quintanilla M., Lobatón C.D., and Sillero A. Dinucleosidetriphosphatase from rat liver; purification and properties. Eur. J. Biochem. 76 (1977) 331-337
22. Rotllán P., Rodríguez-Ferrer C.R., Asensio A.C., and Oaknin S. Potent inhibition of specific diadenosine polyphosphate hydrolases by suramin. FEBS Lett. 429 (1998) 143-146
23. Asensio A.C., Oaknin S., and Rotllán P. Fluorimetric detection of enzymatic activity associated to the human tumour suppressor Fhit protein. Biochim. Biophys. Acta 1432 (1999) 396-400
24. Costas M.J., Montero J.M., Cameselle J.C., Günther-Sillero M.A., and Sillero A. Dinucleosidetriphosphatase from rat brain. Int. J. Biochem. 16 (1984) 757-762
25. Asensio A.C., Rodríguez-Ferrer C.R., Oaknin S., and Rotllán P. Human diadenosine triphosphate hydrolase: preliminary characterisation and comparison with the Fhit protein, a human tumour suppressor. Acta Biochim. Pol. 47 (2000) 435-441
26. Voogd T.E., Vansterkenburg E.L.M., Wilting J., and Janssen L.H.M. Recent research on the biological activity of suramin. Pharmacol. Rev. 45 (1993) 177-203
27. Roboz J., Deng L., Ma L., and Holland J.F. Investigation of suramin-albumin binding by electrospray mass spectrometry. Rapid Commun. Mass Spectrom. 12 (1998) 1319-1322
28. Vishwanatha J.K., and Wei Z. Diadenosine tetraphosphate binding protein from human HeLa cells: purification and characterization. Biochemistry 31 (1992) 1631-1635
29. 4-tetraphosphate hydrolase is present in human erythrocytes, leukocytes and platelets. Int. J. Biochem. Cell Biol. 27 (1995) 201-206
30. 3-triphosphate hydrolase from yellow lupin (Lupinus luteus) seeds: purification to homogeneity and hydrolysis of mRNA 5′- cap analogs. Protein Expr. Purif. 8 (1996) 416-422
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
32. Wilson C.M. Staining of proteins on gels: comparison of dyes and procedures. Methods Enzymol. 91 (1983) 236-247
33. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
34. 4-tetraphosphate are present and releasable, but metabolically inactive, in human platelets. Biochem. J. 208 (1982) 737-742
35. 3A) in human platelets. Biochem. Biophys. Res. Commun. 115 (1983) 253-262
36. Brevet A., Chen J., Fromant M., Blanquet S., and Plateau P. Isolation and characterization of a dinucleoside triphosphatase from Saccharomyces cerevisiae. J. Bacteriol. 173 (1991) 5275-5279
37. Presscott M.P., Thorne N.M.H., Milne A.D., and McLennan A.G. Characterisation of a bis(5′-nucleosidyl) triphosphate pyrophosphohydrolase from encysted embryos of the brine shrimp Artemia. Int. J. Biochem. 24 (1992) 565-571
38. Chaudhuri A.R., Khan I.A., Prasad V., Robinson A.K., Ludueña R.F., and Barnes L.D. The tumor suppressor protein Fhit. A novel interaction with tubulin. J. Biol. Chem. 274 (1999) 24378-24382
39. Pace H.C., Hadawadekar S.C., Draganescu A., Huang J., Bieganowski P., Pekarsky Y., Croce C.M., and Brenner C. Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimmers. Curr. Biol. 10 (2000) 907-917
40. Shi Y., Zou M., Farid N.R., and Paterson M.C. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem. J. 352 (2000) 443-448
41. Chen J., Brevet A., Blanquet S., and Plateau P. Control of 5′,5′-dinucleoside triphosphate catabolism by APH1, a Saccharomyces cerevisiae analog of human FHIT. J. Bacteriol. 180 (1998) 2345-2349
42. 3-triphosphate hydrolases in rat brain: two specific dinucleoside triphosphatases and two phosphodiesterase I-like hydrolases. Biochim. Biophys. Acta 1073 (1991) 402-409
43. Hofseth L.J., Hussain S.P., and Harris C.C. p53: 25 years after its discovery. Trends Pharmacol. Sci. 25 (2004) 177-181
44. Trapasso F., Krakowiak A., Cesari R., Arkles J., Yendamuri S., Ishii H., Vecchione A., Kuroki T., Bieganowski P., Pace H.C., Huebner K., Croce C.M., and Brenner C. Designed FHIT alleles establish that Fhit-Induced apoptosis in cancer cells is limited by substrate-binding. Proc. Natl. Acad. Sci. USA 100 (2003) 1592-1597
45. 4A ratio in human cell cultures. FEBS Lett. 415 (1997) 160-162
46. Kuyu H., Lee W.R., Bare R., Hall M.C., and Torti F.M. Recent advances in the treatment of prostate cancer. Ann. Oncol. 10 (1999) 891-898
47. Kaur M., Reed E., Sartor O., Dahut W., and Figg W.D. Suramin's development: what did we learn?. Invest. New Drugs 20 (2002) 209-219
48. Bojanowski K., Lelievre S., Markovits J., Couprie J., Jacquemin-Sablon A., and Larsen A.K. Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells. Proc. Natl. Acad. Sci. USA 89 (1992) 3025-3029
49. Gagliardi A.R.T., Taylor M.F., and Collins D.C. Uptake of suramin by human microvascular endothelial cells. Cancer Lett. 125 (1998) 97-102
50. Gill J.S., and Windebank A.J. Role of ceramide in suramin-induced cancer cell death. Cancer Lett. 119 (1997) 169-176
51. Gill J.S., and Windebank A.J. Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons. Cell Death Differ. 5 (1998) 876-883
52. Eichhorst S.T., Krueger A., Müerköster S., Fas S.C., Golks A., Gruetzner U., Schubert L., Opelz C., Bilzer M., Gerbes A.L., and Krammer P.H. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat. Med. 10 (2004) 602-609